Chapter/Section Purchase

1 Study Coverage
1.1 Narcolepsy Therapeutics Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Narcolepsy Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Narcolepsy Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Narcolepsy Therapeutics Market Size for the Year 2017-2028
1.3 Narcolepsy Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Narcolepsy Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Narcolepsy Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Narcolepsy Therapeutics Market Dynamics
1.4.1 Narcolepsy Therapeutics Industry Trends
1.4.2 Narcolepsy Therapeutics Market Drivers
1.4.3 Narcolepsy Therapeutics Market Challenges
1.4.4 Narcolepsy Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Narcolepsy Therapeutics by Type
2.1 Narcolepsy Therapeutics Market Segment by Type
2.1.1 Central nervous system stimulants
2.1.2 Sodium Oxybate
2.1.3 Selective Serotonin Reuptake Inhibitor (SSRI)
2.1.4 Tricyclic Antidepressants
2.1.5 Others
2.2 Global Narcolepsy Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Narcolepsy Therapeutics Market Size by Type (2017-2028)
2.4 United States Narcolepsy Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Narcolepsy Therapeutics Market Size by Type (2017-2028)
3 Narcolepsy Therapeutics by Application
3.1 Narcolepsy Therapeutics Market Segment by Application
3.1.1 Narcolepsy With Cataplexy
3.1.2 Narcolepsy Without Cataplexy
3.1.3 Secondary Narcolepsy
3.2 Global Narcolepsy Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Narcolepsy Therapeutics Market Size by Application (2017-2028)
3.4 United States Narcolepsy Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Narcolepsy Therapeutics Market Size by Application (2017-2028)
4 Global Narcolepsy Therapeutics Competitor Landscape by Company
4.1 Global Narcolepsy Therapeutics Market Size by Company
4.1.1 Top Global Narcolepsy Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Narcolepsy Therapeutics Revenue by Player (2017-2022)
4.2 Global Narcolepsy Therapeutics Concentration Ratio (CR)
4.2.1 Narcolepsy Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Narcolepsy Therapeutics in 2021
4.2.3 Global Narcolepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Narcolepsy Therapeutics Headquarters, Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Narcolepsy Therapeutics Headquarters and Area Served
4.3.2 Global Narcolepsy Therapeutics Companies Revenue in Narcolepsy Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Narcolepsy Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Narcolepsy Therapeutics Market Size by Company
4.5.1 Top Narcolepsy Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Narcolepsy Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Narcolepsy Therapeutics Market Size by Region
5.1 Global Narcolepsy Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Narcolepsy Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Narcolepsy Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Narcolepsy Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Narcolepsy Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Narcolepsy Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Narcolepsy Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Narcolepsy Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Narcolepsy Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Narcolepsy Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Narcolepsy Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Narcolepsy Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Narcolepsy Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Narcolepsy Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Addrenex Pharmaceuticals, Inc.
7.1.1 Addrenex Pharmaceuticals, Inc. Company Details
7.1.2 Addrenex Pharmaceuticals, Inc. Business Overview
7.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
7.1.4 Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
7.1.5 Addrenex Pharmaceuticals, Inc. Recent Development
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Teva Pharmaceutical Industries Ltd. Company Details
7.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Introduction
7.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2017-2022)
7.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.3 Jazz Pharmaceuticals PLC
7.3.1 Jazz Pharmaceuticals PLC Company Details
7.3.2 Jazz Pharmaceuticals PLC Business Overview
7.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Introduction
7.3.4 Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2017-2022)
7.3.5 Jazz Pharmaceuticals PLC Recent Development
7.4 Graymark Healthcare, Inc.
7.4.1 Graymark Healthcare, Inc. Company Details
7.4.2 Graymark Healthcare, Inc. Business Overview
7.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Introduction
7.4.4 Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
7.4.5 Graymark Healthcare, Inc. Recent Development
7.5 Arena Pharmaceuticals, Inc.
7.5.1 Arena Pharmaceuticals, Inc. Company Details
7.5.2 Arena Pharmaceuticals, Inc. Business Overview
7.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
7.5.4 Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
7.5.5 Arena Pharmaceuticals, Inc. Recent Development
7.6 BIOPROJET
7.6.1 BIOPROJET Company Details
7.6.2 BIOPROJET Business Overview
7.6.3 BIOPROJET Narcolepsy Therapeutics Introduction
7.6.4 BIOPROJET Revenue in Narcolepsy Therapeutics Business (2017-2022)
7.6.5 BIOPROJET Recent Development
7.7 Takeda
7.7.1 Takeda Company Details
7.7.2 Takeda Business Overview
7.7.3 Takeda Narcolepsy Therapeutics Introduction
7.7.4 Takeda Revenue in Narcolepsy Therapeutics Business (2017-2022)
7.7.5 Takeda Recent Development
7.8 Ligand Pharmaceuticals, Inc.
7.8.1 Ligand Pharmaceuticals, Inc. Company Details
7.8.2 Ligand Pharmaceuticals, Inc. Business Overview
7.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
7.8.4 Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2017-2022)
7.8.5 Ligand Pharmaceuticals, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer